KLBF:IDX
Kalbe Farma Tbk PT
IDRÂ 720.00
0.00%
(0.00) 1D
Oct 23, 4:09:12 PM GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDRÂ 715
High
IDRÂ 735
Low
IDRÂ 715
Mkt. cap
33.71T
Avg. vol.
61.58M
Volume
0.00
Dividend
2.78%
Quarterly dividend
IDRÂ 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.05
52-wk high
IDRÂ 1,345
52-wk low
IDRÂ 630
EPS
IDRÂ 80
Shares outstanding
46.81B
No. of employees
13K
Open
IDRÂ 715
High
IDRÂ 735
Low
IDRÂ 715
Mkt. cap
33.71T
Avg. vol.
61.58M
Volume
0.00
Dividend
2.78%
Quarterly dividend
IDRÂ 5
Ex-dividend date
Jun 4, 2026
P/E ratio
9.05
52-wk high
IDRÂ 1,345
52-wk low
IDRÂ 630
EPS
IDRÂ 80
Shares outstanding
46.81B
No. of employees
13K
News stories
From web sources and news partners
Traders Union
·
30 minutes ago
S&P 500 has averaged 1.9 percent gain in November since 1950, Phil Rosen notes
24/7 Wall St.
·
8 minutes ago
3 Dividend ETFs With Over $10 Billion Each Pay Up to 3.31% and Beat the S&P 500 Over the Past Year
Seeking Alpha
·
46 minutes ago
The S&P 500 Is At A Crossroads, That's A Buying Opportunity (SP500)
Yahoo Finance
·
5 hours ago
Dow: 3 Key Takeaways for Long-Term Investors
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT